Prognostic Value of Plasma Pentraxin-3 Levels in Patients with Stable Coronary Artery Disease after Drug-Eluting Stent Implantation

Table 3

Risk stratification of patients after coronary stent implantation based on increased PTX3 (above the median value of 4.384 ng/mL).

PTX3 (ng/mL)	Overall	>4.384	<4.384
	596	297	299
MACEs, (%)	82 (13.8)	61 (20.5)	21 (7.0)	0.000
Cardiac death, (%)	22 (3.7)	14 (4.7)	8 (2.7)	0.200
Nonfatal MI, (%)	14 (2.3)	11 (3.7)	3 (1.0)	0.033
TVR, (%)	46 (7.7)	36 (12.1)	10 (3.3)	0.00008

MACEs: major adverse cardiovascular events; MI: myocardial infarction; TVR: target vessel revascularization.